U.S. Fertility Test Market - Industry Outlook & Forecast 2022-2027

151 pages

47 tables

73 charts

1 region

1 countries

26 company

4 segments

Purchase Options

$3500.00
$3995.00
$4995.00
$1500.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

U.S. FERTILITY TEST MARKET  IS PROJECTED TO REACH USD 201.4 MILLION IN 2027 FROM USD 133.5 MILLION IN 2021 GROWING AT A CAGR OF  7.09 %.

The U.S. Fertility Test Market Research Report Includes Size by

Product-  

  • Ovulation Test Kits
  • Fertility Monitors
  • Sperm Test Kits

Gender 

  • Male 
  • Female

Distribution Channel 

  • Online Sales Channel
  • Retail Pharmacies
  • Hospital Pharmacies

End-users  

  • Homecare
  • Fertility & Specialty Clinics
  • Hospitals

Trends, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022-2027

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

U.S. FERTILITY TEST MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
MARKET SIZE(2027)USD 201.4 MILLION
MARKET SIZE(2021)USD 133.5 MILLION
CAGR(2022-2027)7.09%
BASE YEAR2021
FORECAST YEAR2022-2027
MARKET SEGMENTSProduct (Ovulation Test Kits, Fertility Monitors, and Sperm Test Kits), Gender (Male and Female), Distribution Channel (Online Sales Channel, Retail Pharmacies, and Hospital Pharmacies), End-user (Homecare, Fertility & Specialty Clinics, and Hospitals)
LARGEST MARKET BY PRODUCTOvulation Test kits
LARGEST SALES CHANNELSOnline Sales
COUNTRY COVEREDU.S.
Interested in this Report?

Download a Sample!

U.S. FERTILITY TEST MARKET OVERVIEW   

U.S. fertility test market is projected to reach USD 201.4 million in 2027 from USD 133.5 million in 2021, growing at a CAGR of 7.09%. A fertility test is a procedure by which the fertility of males or females can assess and search the fertile window during a month. Fertility tests are assessed by ovulation test kits, fertility monitors, and sperm testing. The increasing infertility prevalence and rising maternal age directly impact male and female fertility, driving the demand for fertility tests. The U.S. fertility test market is likely to develop due to favorable demographic and social/cultural shifts due to attractive long-term growth. 

With the help of testing, gynecologists/doctors quickly analyze the barrier factors that restrict the pregnancy. Moreover, the increasing awareness in teenagers and maternal age groups, both men and women, is driving the demand for home care kits. The rapidly advancing medical device industry has made a significant impact on the growth of the global fertility test market. The industry is highly competitive, and the vendors are increasingly focused on making partnerships and broadening the product portfolio to maintain a competitive edge over other players.

KEY HIGHLIGHTS  OF THE U.S. FERTILITY TEST MARKET

  • Recently, homecare test kits have been increasing rapidly due to convenience in testing, affordable price, easy availability, ease of carrying, and safer options during the pandemic.  
  • The average marriage age increases year by year in the U.S. as young individuals care about their career and financial stability more than marriage. Increasing age can lead to infertility both in male and female bodies. This is driving demand in the U.S. Fertility testing devices market.   
  • The online sales distribution channel in the industry is expected to witness absolute growth of over 55% during the forecast period. Amazon, Flipkart, & online pharmacies such as apollo pharmacies, very well health, PharmEasy, Hims, Medlife, and GoodRx are some of the country's online sale distribution channels. The impact of COVID-19 has boosted sales through online distribution channels. 

U.S. FERTILITY TEST MARKET OPPORTUNITIES & TRENDS

Increasing Adoption of At-Home Fertility Testing Kits.

As per the National Centre for Biotechnology Information study report, home-based fertility testing devices are easy to use and provide accurate results that are easy to understand. The introduction of digital display with test kits also made it easier to interpret the results, which propelled the higher adoption of the kits leading to the growth of the market. The availability of fertility tests such as ovulation test kits. Fertility monitors and sperm test kits by e-commerce channels, hospitals pharmacies, and retail pharmacies give tremendous opportunity for market growth.

Due to the rising concern and increasing awareness, the male fertility sperm test is also made widely available. Most of the time, men hesitate to visit clinics or fertility centers for testing. They can do the same at the convenience of their home using home test kits. As fertility services are costly in the U.S., patients opt for at-home fertility testing kits to test, monitor and conceive.

Rising Concern About Infertility And Increasing Hospital Visits.

The government support for family planning and reproductive health has helped raise fertility-related awareness in the U.S. The U.S. government has supported people for reproductive health (R.H.) and family planning (F.P.) for the last 50 years. It has now shifted the focus on the concern about fertility problems. The U.S. is a large market for fertility tests and services.

U.S. FERTILITY TEST MARKET SEGMENTS    

The ovulation test kit market accounted for more than 56% of the U.S. fertility test market share due to the increasing population of first-time pregnancies in maternal age groups and the increasing prevalence of infertility cases across the U.S. Some women experience irregular ovulation in the U.S., which triggers the market growth to determine the fertility window and the menstrual cycle. Around 10% of males in the United States suffer from infertility problems. The growing prevalence of infertility cases in males due to external factors such as consumption of alcohol, tobacco, and marijuana and environmental pollution are escalating the demand for sperm test kits.

In the United States, the female segment accounted for more than 70% of the share in 2021 due to the change in women's lifestyles and rising awareness about personal health. Due to the high acceptance of fertility testing kits as compared to males. Reproduction-related issues and the high prevalence of hormonal disorders such as PCOS drive market growth.

The rising adoption of E-commerce channels for consumable healthcare products has fuelled the sales of fertility testing kits online. The availability of a wide range of products on online sales channels concerning the price competitiveness; buyers can easily compare products before buying. Increasing internet penetration and the rising smartphone population will give a new opportunity for market growth. The availability of digital fertility testing kits created a unique opportunity in the U.S. market.  The online sales channel is projected to sell more fertility test kits than retail pharmacies and hospital pharmacies. The online market is expected to grow at a CAGR of more than 7% from 2022 to 2027.

VENDOR LANDSCAPE   

  • Large players are forming strategic alliances and entering co-marketing agreements to increase their competitiveness and penetration in the market. 
  • New start-ups and product launches maintain competitiveness in the arena. For instance, Legacy has come up with sperm freezing technology. India-based Inito also has launched a portable ovulation test kit.  
  • E-commerce is the best way to acquire a high customer base, and this strategy is approvingly accepted in the U.S. by the industry vendors.  

The U.S. fertility test market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:  

By Product   

  • Ovulation Test Kits  
  • Fertility Monitors  
  • Sperm Test Kits  

By Gender  

  • Male  
  • Female  

By Distribution Channel  

  • Online Sales Channel  
  • Retail Pharmacies  
  • Hospital Pharmacies  

By End-users   

  • Homecare  
  • Fertility & Specialty Clinics 
  • Hospitals  

Frequently Asked Questions

What is the total value of the U.S. fertility test market by 2027? 

The U.S. fertility test market is projected to reach USD 201.37 million by 2027.

By 2027 which sales channel will sell more fertility test kits?

Online sales channel is projected to sell more fertility test kits than retail pharmacies and hospital pharmacies. The online market is expected to grow at a CAGR of more than 7% from 2022-2027.

What are the key trends in the U.S. fertility testing industry?

The key trends in the industry are the rising prevalence of sperm kits amongst men, more preference for online buying channels and, increasing hormonal disorders amongst women.

Which product segment is expected to garner the highest traction within the U.S. fertility test market?

Ovulation test kits are expected to garner the highest traction.

The U.S. fertility test market size was valued at USD 133.49 million in 2020 and is expected to reach USD 201.37 million by 2026, growing at a CAGR of 7.09 % during the forecast period 

The following factors are likely to contribute to the growth of the U.S. fertility test market-  

  • Increasing Adoption of At-Home Fertility Testing Kits  
  • Late Marriages & Pregnancy Trends in the US
  • Rising Acceptance of Sperm Test Kits by Men
  • Rising Concern About Infertility & Increasing Hospital Visits
  • Increasing Maternal Age & Late Marriages  
  • Increasing Prevalence of the Infertility Causing Diseases

Base Year: 2021  

Forecast Year: 2022-2027  

The study considers a detailed scenario of the present U.S. fertility test market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.  

Key Vendors  

  • AB Analitica
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Advacare Pharma
  • Biozhena
  • DNA Diagnostics Center
  • Vio Health Tech
  • Fairhaven Health
  • Hamilton Thorne
  • Hilin Life Products
  • Give Legacy Inc
  • iXensor
  • Lady Technologies
  • LetsGetChecked
  • Medical Electronic System
  • Modern fertility Inc 
  • Natalist
  • OOVA
  • Premom
  • Quanovate
  • Raiing Medical
  • Sugentech
  • Samplytics Technologies Private Limited
  • SwimCount
  • Swiss Precision Diagnostics (SPD)
  • Teco Diagnostic
  • UEBE Medical GmbH
  • Valley Electronics AG

Segmentation by Product-  

  • Ovulation Test Kits
  • Fertility Monitors
  • Sperm Test Kits

Segmentation by Gender 

  • Male 
  • Female

Segmentation by Distribution Channel 

  • Online Sales Channel
  • Retail Pharmacies
  • Hospital Pharmacies

Segmentation by End-users  

  • Homecare
  • Fertility & Specialty Clinics
  • Hospitals

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF US FERTILITY TESTS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 COMMON CAUSES OF INFERTILITY (% SHARE)

EXHIBIT 4 SYMPTOMS OF INFERTILITY AMONG MEN AND WOMEN

EXHIBIT 5 BIRTH RATE BY MATERNAL AGE PER 1,000 WOMEN IN US 2017-2019

EXHIBIT 6 IMPACT OF INCREASING ADOPTION OF AT-HOME FERTILITY TESTING KITS

EXHIBIT 7 US: BIRTH RATE BY MATERNAL AGE PER 1,000 WOMEN 2017-2019

EXHIBIT 8 IMPACT OF LATE MARRIAGES & PREGNANCY TRENDS IN THE US

EXHIBIT 9 US: DELAY IN MARRIAGE PER 1,000 POPULATION (%)

EXHIBIT 10 US: MEDIAN AGE AT FIRST MARRIAGE (1980-2021)

EXHIBIT 11 IMPACT OF RISING ACCEPTANCE OF SPERM TEST KITS BY MEN

EXHIBIT 12 IMPACT OF RISING CONCERN OVER INFERTILITY & INCREASING HOSPITAL VISITS

EXHIBIT 13 US WOMEN & THEIR PARTNERS SEEKING FERTILITY SERVICES TO BECOME PREGNANT (2015-2017)

EXHIBIT 14 IMPACT OF INCREASING MATERNAL AGE & LATE MARRIAGES

EXHIBIT 15 US BIRTH RATE BY MATERNAL AGE 2017-2019

EXHIBIT 16 IMPACT OF PREVALENCE OF INFERTILITY-CAUSING DISEASES

EXHIBIT 17 INFERTILITY CAUSING DISEASES AMONG MEN & WOMEN

EXHIBIT 18 IMPACT OF INCREASING AWARENESS OF FERTILITY PROBLEMS

EXHIBIT 19 IMPACT OF ALTERNATIVE TEST OPTIONS FOR FERTILITY TEST KITS

EXHIBIT 20 IMPACT OF ACCURACY & KNOWLEDGE OF FERTILITY CARE

EXHIBIT 21 US FERTILITY TEST MARKET BY PRODUCT

EXHIBIT 22 US FERTILITY TEST MARKET BY GENDER

EXHIBIT 23 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS

EXHIBIT 24 US FERTILITY TEST MARKET BY END-USER

EXHIBIT 25 US FERTILITY TEST MARKET 2021–2027 ($ MILLION)

EXHIBIT 26 FIVE FORCES ANALYSIS 2021

EXHIBIT 27 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 28 US FERTILITY TEST MARKET BY PRODUCTS 2021-2027

EXHIBIT 29 US FERTILITY TEST MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 30 US FERTILITY TEST MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 31 ADVANTAGES OF OVULATION TEST

EXHIBIT 32 US FERTILITY TEST MARKET BY OVULATION TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 33 US FERTILITY TEST MARKET BY OVULATION TEST KIT 2021–2027 ($ MILLION)

EXHIBIT 34 US: PERCENTAGE OF BIRTH BY MATERNAL AGE

EXHIBIT 35 US FERTILITY TEST MARKET BY FERTILITY MONITORS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 36 US FERTILITY TEST MARKET BY FERTILITY MONITORS 2021–2027 ($ MILLION)

EXHIBIT 37 CAUSES OF MALE INFERTILITY

EXHIBIT 38 US: FACTORS CAUSING MALE INFERTILITY

EXHIBIT 39 US FERTILITY TEST MARKET BY SPERM TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 40 US FERTILITY TEST MARKET BY SPERM TEST KITS 2021–2027 ($ MILLION)

EXHIBIT 41 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 42 US FERTILITY TEST MARKET BY GENDER 2021-2027

EXHIBIT 43 US FERTILITY TEST MARKET BY GENDER: INCREMENTAL GROWTH

EXHIBIT 44 US FERTILITY TEST MARKET BY GENDER: ABSOLUTE GROWTH

EXHIBIT 45 US: AVERAGE NUMBER OF BIRTH PER WOMEN

EXHIBIT 46 US BIRTH RATE BY RACIAL & ETHNIC GROUPS 2020 (%)

EXHIBIT 47 US: TEEN BIRTH RATE PER 1,000 FEMALE AMONG 15 TO 19-YEAR-OLDS

EXHIBIT 48 US: WOMEN AGED 35 TO 44 YEARS REPORTING FERTILITY TREATMENTS 2019 (%)

EXHIBIT 49 US FERTILITY TEST MARKET BY FEMALE: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 50 US FERTILITY TEST MARKET BY FEMALE 2021–2027 ($ MILLION)

EXHIBIT 51 US FERTILITY TEST MARKET BY MALE: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 52 MALE FERTILITY TEST MARKET IN US 2021–2027 ($ MILLION)

EXHIBIT 53 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 54 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021-2027

EXHIBIT 55 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH

EXHIBIT 56 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH

EXHIBIT 57 US FERTILITY TEST MARKET BY ONLINE SALES CHANNELS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 58 US FERTILITY TEST MARKET BY ONLINE SALES CHANNEL 2021–2027 ($ MILLION)

EXHIBIT 59 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 60 US FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021–2027 ($ MILLION)

EXHIBIT 61 US FERTILITY TEST MARKET BY HOSPITAL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 62 US FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021–2027 ($ MILLION)

EXHIBIT 63 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 64 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021-2027

EXHIBIT 65 US FERTILITY TEST MARKET BY END USER: INCREMENTAL GROWTH

EXHIBIT 66 US FERTILITY TEST MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 67 FERTILITY TEST PRODUCTS IN HOMECARE

EXHIBIT 68 US FERTILITY TEST MARKET BY HOMECARE: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 69 US HOMECARE FERTILITY TEST MARKET 2021–2027 ($ MILLION)

EXHIBIT 70 US FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 71 US FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021–2027 ($ MILLION)

EXHIBIT 72 US FERTILITY TEST MARKET BY HOSPITALS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 73 US FERTILITY TEST MARKET BY HOSPITALS 2021–2027 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 US FERTILITY TEST KIT MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 4 US HEALTHCARE DENIAL MANAGEMENT MARKET BY PRODUCT 2021−2027 (%)

TABLE 5 LIST OF SOME OF THE OVULATION TEST KITS AVAILABLE IN THE US

TABLE 6 LIST OF FEW FERTILITY MONITORS AVAILABLE IN US

TABLE 7 US FERTILITY TEST MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 8 US FERTILITY TEST MARKET BY GENDER 2021−2027 (%)

TABLE 9 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021−2027 ($ MILLION)

TABLE 10 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021−2027 (%)

TABLE 11 US FERTILITY TEST MARKET BY END-USERS 2021−2027 ($ MILLION)

TABLE 12 US FERTILITY TEST MARKET BY END-USER 2021−2027 (%)

TABLE 13 TOP TEN IVF CLINICS AVAILABLE IN US

TABLE 14 AB ANALITICA: MAJOR PRODUCT OFFERINGS

TABLE 15 ADVACARE PHARMA: MAJOR PRODUCT OFFERINGS

TABLE 16 BIOZHENA: MAJOR PRODUCT OFFERINGS

TABLE 17 DNA DIAGNOSTICS CENTER: MAJOR PRODUCT OFFERINGS

TABLE 18 VIO HEALTH TECH: MAJOR PRODUCT OFFERINGS

TABLE 19 FAIRHAVEN HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 20 HAMILTON THORNE: MAJOR PRODUCT OFFERINGS

TABLE 21 HILIN LIFE PRODUCTS: MAJOR PRODUCT OFFERINGS

TABLE 22 GIVE LEGACY: MAJOR PRODUCT OFFERINGS

TABLE 23 IXENSOR: MAJOR PRODUCT OFFERINGS

TABLE 24 LADY TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 25 LETSGETCHECKED: MAJOR PRODUCT OFFERINGS

TABLE 26 MEDICAL ELECTRONIC SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 27 MODERN FERTILITY: MAJOR PRODUCT OFFERINGS

TABLE 28 NATALIST: MAJOR PRODUCT OFFERINGS

TABLE 29 OOVA: MAJOR PRODUCT OFFERINGS

TABLE 30 PREMOM: MAJOR PRODUCT OFFERINGS

TABLE 31 QUANOVATE: MAJOR PRODUCT OFFERINGS

TABLE 32 RAIING MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 33 SUGENTECH: MAJOR PRODUCT OFFERINGS

TABLE 34 SAMPLYTICS TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 35 SWIMCOUNT: MAJOR PRODUCT OFFERINGS

TABLE 36 SWISS PRECISION DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 37 TECO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 38 UEBE MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 39 VALLEY ELECTRONICS: MAJOR PRODUCT OFFERINGS

TABLE 40 US FERTILITY TEST KIT MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 41 US HEALTHCARE DENIAL MANAGEMENT MARKET BY PRODUCT 2021−2027 (%)

TABLE 42 US FERTILITY TEST MARKET BY GENDER 2021−2027 ($ MILLION)

TABLE 43 US FERTILITY TEST MARKET BY GENDER 2021−2027 (%)

TABLE 44 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021−2027 ($ MILLION)

TABLE 45 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021−2027 (%)

TABLE 46 US FERTILITY TEST MARKET BY END USERS 2021−2027 ($ MILLION)

TABLE 47 US FERTILITY TEST MARKET BY END USER 2021−2027 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY GENDER

4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS

4.3.4 MARKET SEGMENTATION BY END USER

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 INCREASING ADOPTION OF AT-HOME FERTILITY TESTING KITS

8.2 LATE MARRIAGES AND PREGNANCY TRENDS IN THE US

8.3 RISING ACCEPTANCE OF SPERM TEST KITS BY MEN

9 MARKET GROWTH ENABLERS

9.1 RISING CONCERN OVER INFERTILITY AND INCREASING HOSPITAL VISITS

9.2 INCREASING MATERNAL AGE & LATE MARRIAGES

9.3 PREVALENCE OF INFERTILITY-CAUSING DISEASES

9.4 INCREASING AWARENESS OF FERTILITY PROBLEMS

10 MARKET RESTRAINTS

10.1 ALTERNATIVE TEST OPTIONS FOR FERTILITY TEST KITS

10.2 ACCURACY & KNOWLEDGE OF FERTILITY CARE

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.1.1 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: PRODUCT SEGMENTATION INSIGHTS

11.1.2 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: GENDER SEGMENTATION INSIGHTS

11.1.3 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: DISTRIBUTION CHANNEL SEGMENTATION INSIGHTS

11.1.4 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: END-USER SEGMENTATION INSIGHTS

11.2 MARKET SIZE & FORECAST

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 PRODUCT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.2.1 INCREMENTAL & ABSOLUTE GROWTH BY PRODUCT

12.3 PRODUCT

12.4 OVULATION TEST KIT

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.5 FERTILITY MONITORS

12.5.1 MARKET OVERVIEW

12.5.2 MARKET SIZE & FORECAST

12.6 SPERM TEST KITS

12.6.1 MARKET OVERVIEW

12.6.2 MARKET SIZE & FORECAST

13 GENDER

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.2.1 INCREMENTAL GROWTH & ABSOLUTE GROWTH BY GENDER SEGMENT

13.3 GENDER

13.4 FEMALE

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.5 MALE

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

14 DISTRIBUTION CHANNEL

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.2.1 INCREMENTAL GROWTH & ABSOLUTE GROWTH BY GENDER SEGMENT

14.3 DISTRIBUTION CHANNEL

14.4 ONLINE SALES CHANNEL

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.5 RETAIL PHARMACIES

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.6 HOSPITAL PHARMACIES

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

15 END-USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.2.1 INCREMENTAL GROWTH & ABSOLUTE GROWTH BY END-USER

15.3 END-USER

15.4 HOMECARE

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.5 FERTILITY & SPECIALTY HOSPITALS

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.6 HOSPITALS

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

16 COMPETITIVE LANDSCAPE

16.1 COMPETITION OVERVIEW

16.2 MARKET SHARE ANALYSIS

16.2.1 AB ANALITICA

16.2.2 ADVACARE PHARMA

16.2.3 BIOZHENA

16.2.4 DNA DIAGNOSTICS CENTER

16.2.5 FAIRHAVEN HEALTH

16.2.6 HILIN LIFE

17 KEY COMPANY PROFILES

17.1 AB ANALITICA

17.1.1 BUSINESS OVERVIEW

17.1.2 PRODUCT OFFERINGS

17.2 ADVACARE PHARMA

17.2.1 BUSINESS OVERVIEW

17.2.2 PRODUCT OFFERINGS

17.3 BIOZHENA

17.3.1 BUSINESS OVERVIEW

17.3.2 PRODUCT OFFERINGS

17.4 DNA DIAGNOSTICS CENTER

17.4.1 BUSINESS OVERVIEW

17.4.2 PRODUCT OFFERINGS

17.5 VIO HEALTH TECH

17.5.1 BUSINESS OVERVIEW

17.5.2 PRODUCT OFFERINGS

17.6 FAIRHAVEN HEALTH

17.6.1 BUSINESS OVERVIEW

17.6.2 PRODUCT OFFERINGS

17.7 HAMILTON THORNE

17.7.1 BUSINESS OVERVIEW

17.7.2 PRODUCT OFFERINGS

17.8 HILIN LIFE PRODUCTS

17.8.1 BUSINESS OVERVIEW

17.8.2 PRODUCT OFFERINGS

17.9 GIVE LEGACY

17.9.1 BUSINESS OVERVIEW

17.9.2 PRODUCT OFFERINGS

17.10 IXENSOR

17.10.1 BUSINESS OVERVIEW

17.10.2 PRODUCT OFFERINGS

17.11 LADY TECHNOLOGIES

17.11.1 BUSINESS OVERVIEW

17.11.2 PRODUCT OFFERINGS

17.12 LETSGETCHECKED

17.12.1 BUSINESS OVERVIEW

17.12.2 PRODUCT OFFERINGS

17.13 MEDICAL ELECTRONIC SYSTEMS

17.13.1 BUSINESS OVERVIEW

17.13.2 PRODUCT OFFERINGS

17.14 MODERN FERTILITY

17.14.1 BUSINESS OVERVIEW

17.14.2 PRODUCT OFFERINGS

17.15 NATALIST

17.15.1 BUSINESS OVERVIEW

17.15.2 PRODUCT OFFERINGS

17.16 OOVA

17.16.1 BUSINESS OVERVIEW

17.16.2 PRODUCT OFFERINGS

17.17 PREMOM

17.17.1 BUSINESS OVERVIEW

17.17.2 PRODUCT OFFERINGS

17.18 QUANOVATE

17.18.1 BUSINESS OVERVIEW

17.18.2 PRODUCT OFFERINGS

17.19 RAIING MEDICAL

17.19.1 BUSINESS OVERVIEW

17.19.2 PRODUCT OFFERINGS

17.20 SUGENTECH

17.20.1 BUSINESS OVERVIEW

17.20.2 PRODUCT OFFERINGS

17.21 SAMPLYTICS TECHNOLOGIES PRIVATE LIMITED

17.21.1 BUSINESS OVERVIEW

17.21.2 PRODUCT OFFERINGS

17.22 SWIMCOUNT

17.22.1 BUSINESS OVERVIEW

17.22.2 PRODUCT OFFERINGS

17.23 SWISS PRECISION DIAGNOSTICS

17.23.1 BUSINESS OVERVIEW

17.23.2 PRODUCT OFFERINGS

17.24 TECO DIAGNOSTICS

17.24.1 BUSINESS OVERVIEW

17.24.2 PRODUCT OFFERINGS

17.25 UEBE MEDICAL

17.25.1 BUSINESS OVERVIEW

17.25.2 PRODUCT OFFERINGS

17.26 VALLEY ELECTRONICS

17.26.1 BUSINESS OVERVIEW

17.26.2 PRODUCT OFFERINGS

 

18 REPORT SUMMARY

18.1 KEY TAKEAWAYS

18.2 STRATEGIC RECOMMENDATIONS

19 QUANTITATIVE SUMMARY

19.1 PRODUCT

19.2 GENDER

19.3 DISTRIBUTION CHANNEL

19.4 END-USER

20 APPENDIX

20.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

What is the total value of the U.S. fertility test market by 2027? 

The U.S. fertility test market is projected to reach USD 201.37 million by 2027.

By 2027 which sales channel will sell more fertility test kits?

Online sales channel is projected to sell more fertility test kits than retail pharmacies and hospital pharmacies. The online market is expected to grow at a CAGR of more than 7% from 2022-2027.

What are the key trends in the U.S. fertility testing industry?

The key trends in the industry are the rising prevalence of sperm kits amongst men, more preference for online buying channels and, increasing hormonal disorders amongst women.

Which product segment is expected to garner the highest traction within the U.S. fertility test market?

Ovulation test kits are expected to garner the highest traction.